Consistently, MAGEA4, a classical seminoma marker, was significantly downregulated in metastatic seminomas compared to non-metastatic cases, with even lower expression observed in embryonal carcinomas (Fig. S8) [35]. Here, MAGEA4 is linked to embryonal carcinoma.